The question of putative mechanisms of action continues to haunt psychopharmacology ... a disease of deficit of either serotonin or norepinephrine. Lately, we have been focused on the idea ...

“We found that while the pumping of noradrenaline in the brain is constant during natural sleep, drugs such as zolpidem [from ...

Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an sNDA for AXS-05 for the treatment of Alzheimer’s disease agitation. Axsome ...

Introduction Tramadol abuse has emerged as a significant public health crisis in Ghana, particularly among young people, ...

MAXONA Pharmaceuticals today announced the United States Patents and Trademark Office (USPTO) has issued Patent No.

A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...

The activated neurohormones angiotensin II, aldosterone, and norepinephrine promote tubular ... diuretic resistance through a different mechanism of action. In recent years, aldosterone ...

Jack Khattar; President, Chief Executive Officer, Secretary, Director; Supernus Pharmaceuticals Inc Timothy Dec; Chief Financial Officer, Senior Vice President; Supernus Pharmaceuticals Inc Good ...

Q4 2024 Earnings Call Transcript February 26, 2025 Theravance Biopharma, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.26. Operator: Ladies and gentlemen, good ...

The new label further elaborates and differentiates Qelbree's mechanism of action as a novel nonstimulant ... HT2C receptor and inhibition of the norepinephrine transport. Also the label is ...

Similar to cranioelectrical stimulation, trans auricular vagus nerve stimulation shows dramatic potential to treat many brain ...

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...